Characteristics | Total | KRAS | EGFR | P value |
---|---|---|---|---|
No. of patients | 56 | 12 | 44 | Â |
Age (y)a | 55.98 ± 10.37 | 58.75 ± 7.53 | 55.23 ± 10.97 | 0.301 |
Sex | 0.149 | |||
 Female | 29 (51.8) | 4 (33.3) | 25 (56.8) |  |
 Male | 27 (48.2) | 8 (66.7) | 19 (43.2) |  |
Smoking | 0.012 | |||
 Never smoked | 36 (64.3) | 4 (33.3) | 32 (72.7) |  |
 Smoker | 20 (35.7) | 8 (66.7) | 12 (27.3) |  |
Location | 0.452 | |||
 Central | 2 (3.6) | 0 (0.0) | 2 (4.5) |  |
 Peripheral | 54 (96.4) | 12 (100.0) | 42 (95.5) |  |
T stage | 0.148 | |||
 T1–2 | 52 (92.9) | 10 (83.3) | 42 (95.5) |  |
 T3–4 | 4 (7.1) | 2 (16.7) | 2 (4.5) |  |
N stage | 0.158 | |||
 N0 | 32 (57.1) | 9 (7.5) | 23 (52.3) |  |
 N1–2 | 24 (42.9) | 3 (2.5) | 21 (47.7) |  |
Maximum diameterb | 3.15 ± 1.32 | 3.17 ± 1.38 | 3.14 ± 1.32 | 0.742 |
DESCT quantitative parameter | ||||
 CT number at 70 keVa | 47.39 ± 23.04 | 31.52 ± 22.26 | 51.71 ± 21.51 | 0.006 |
 Slope λ HUb | 1.71 ± 0.92 | 1.17 ± 0.77 | 1.85 ± 0.91 | 0.017 |
 NICb | 0.198 ± 0.12 | 0.14 ± 0.09 | 0.21 ± 0.12 | 0.013 |
 NWCb | 0.989 ± 0.02 | 0.98 ± 0.02 | 0.99 ± 0.02 | 0.239 |
 Effective Za | 8.45 ± 0.43 | 8.17 ± 0.39 | 8.52 ± 0.41 | 0.010 |